Literature DB >> 18490471

Effect of osteochondral graft insertion forces on chondrocyte viability.

Shantanu Patil1, William Butcher, Darryl D D'Lima, Nikolai Steklov, William D Bugbee, Heinz R Hoenecke.   

Abstract

BACKGROUND: Because chondrocytes are responsible for articular cartilage matrix synthesis and maintenance, reduced chondrocyte viability could compromise graft survival, healing, and clinical outcome. HYPOTHESIS: Typical forces used in osteochondral grafting reduce the viability of the chondrocytes in the graft. STUDY
DESIGN: Controlled laboratory study.
METHODS: Osteochondral grafting was performed in 4 fresh-frozen cadaver knees (n = 16 per knee). Impact force was measured during extrusion of the donor graft from the harvester into the recipient site, seating the graft flush with the articular surface of the surrounding cartilage using a tamp, and recessing the graft surface below the recipient articular surface. The magnitudes of forces measured during cadaver surgery (200, 400, and 800 N) were reproduced using a drop-tower apparatus on 80 fresh osteochondral grafts harvested from knee blocks provided by tissue banks. Cell viability and glycosaminoglycan release in media were measured at 48 hours after injury.
RESULTS: Forces were relatively low (range, 124-356 N) during graft extrusion from the harvester into the recipient defect or during flush seating (range, 191-418 N) of the graft. Attempts to recess the graft generated significantly greater force (range, 147-685; P < .01). When the donor graft length was 2 mm longer than the depth of the recipient hole, the mean impact force generated was even higher (range, 240-1114 N) than the force seen in a donor graft of equal length. No reduction in viability was seen at 200-N and 400-N impacts. However, a significant decrease in chondrocyte viability was seen in the group impacted with 800 N (only 50% of cells were viable, compared with 91% in the sham group; P < .01). Glycosaminoglycan levels in culture media did not correlate significantly with insertion force.
CONCLUSION: Typical graft insertion forces did not significantly reduce chondrocyte viability. However, increased graft length relative to the depth of the recipient hole and attempts to recess the graft generated higher forces, which reduced chondrocyte viability. CLINICAL RELEVANCE: Any theoretical benefits of cancellous bone compaction that may occur in grafts that are recessed or are longer than the recipient holes must be balanced against the potential reduction in chondrocyte viability.

Entities:  

Mesh:

Year:  2008        PMID: 18490471     DOI: 10.1177/0363546508316765

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  11 in total

1.  Biomechanics of osteochondral impact with cushioning and graft Insertion: Cartilage damage is correlated with delivered energy.

Authors:  Alvin W Su; Yunchan Chen; Yao Dong; Dustin H Wailes; Van W Wong; Albert C Chen; Shengqiang Cai; William D Bugbee; Robert L Sah
Journal:  J Biomech       Date:  2018-03-30       Impact factor: 2.712

2.  The in vivo performance of osteochondral allografts in the goat is diminished with extended storage and decreased cartilage cellularity.

Authors:  Andrea L Pallante; Albert C Chen; Scott T Ball; David Amiel; Koichi Masuda; Robert L Sah; William D Bugbee
Journal:  Am J Sports Med       Date:  2012-06-15       Impact factor: 6.202

3.  Osteochondral Graft Size Is Significantly Associated With Increased Force and Decreased Chondrocyte Viability.

Authors:  Brian E Walczak; Matthew S Nies; Darrin J Trask; Scott Hetzel; Patrick J Roney; Matthew W Squire; Geoffrey S Baer
Journal:  Am J Sports Med       Date:  2018-01-12       Impact factor: 6.202

4.  Impact insertion of osteochondral grafts: Interference fit and central graft reduction affect biomechanics and cartilage damage.

Authors:  Alvin W Su; Yunchan Chen; Dustin H Wailes; Van W Wong; Shengqiang Cai; Albert C Chen; William D Bugbee; Robert L Sah
Journal:  J Orthop Res       Date:  2017-09-05       Impact factor: 3.494

5.  Osteochondral autografts.

Authors:  Shantanu Patil; Sachin R Tapasvi
Journal:  Curr Rev Musculoskelet Med       Date:  2015-12

6.  Transduction of anti-cell death protein FNK suppresses graft degeneration after autologous cylindrical osteochondral transplantation.

Authors:  Noriki Nakachi; Sadamitsu Asoh; Nobuyoshi Watanabe; Takashi Mori; Takashi Matsushita; Shinro Takai; Shigeo Ohta
Journal:  J Histochem Cytochem       Date:  2008-10-27       Impact factor: 2.479

7.  Platelet-Rich Plasma and Hyaluronic Acid Are Not Synergistic When Used as Biological Adjuncts with Autologous Osteochondral Transplantation.

Authors:  Niall A Smyth; Keir A Ross; Amgad M Haleem; Charles P Hannon; Christopher D Murawski; Huong T Do; John G Kennedy
Journal:  Cartilage       Date:  2017-02-08       Impact factor: 4.634

8.  Effect of impaction sequence on osteochondral graft damage: the role of repeated and varying loads.

Authors:  Richard W Kang; Nicole A Friel; James M Williams; Brian J Cole; Markus A Wimmer
Journal:  Am J Sports Med       Date:  2009-11-13       Impact factor: 6.202

9.  Articular Cartilage Repair of the Pediatric and Adolescent Knee with Regard to Minimal Clinically Important Difference: A Systematic Review.

Authors:  Rosa S Valtanen; Armin Arshi; Benjamin V Kelley; Peter D Fabricant; Kristofer J Jones
Journal:  Cartilage       Date:  2018-07-02       Impact factor: 4.634

10.  An Expert Consensus Statement on the Management of Large Chondral and Osteochondral Defects in the Patellofemoral Joint.

Authors:  Jorge Chahla; Betina B Hinckel; Adam B Yanke; Jack Farr; William D Bugbee; James L Carey; Brian J Cole; Dennis C Crawford; James E Fleischli; Alan Getgood; Andreas H Gomoll; Simon Gortz; Allan E Gross; Deryk G Jones; Aaron J Krych; Christian Lattermann; Bert R Mandelbaum; Peter R Mandt; Tom Minas; Raffy Mirzayan; Timothy S Mologne; John D Polousky; Matthew T Provencher; Scott A Rodeo; Oleg Safir; Seth Lawrence Sherman; Eric D Strauss; Sabrina M Strickland; Christopher J Wahl; Riley J Williams
Journal:  Orthop J Sports Med       Date:  2020-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.